Confocal Laserscanning Microscopy for Detection of Barretts Esophagus
Confocal Laserscanning Microscopy for Detection of Barretts Esophagus. A Blinded Multi-Center Study.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bavaria
-
Munich, Bavaria, Germany, 81675
- 2nd department of the Medical Clinic of the Technical University Munich
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age between 18 and 80 years
- regular esophagogastroduodenoscopy for patients with known barrett esophagus (at least stadium C0M1)
- patients presenting for endoscopic mucosectomy with intraepithelial neoplastic changes <1cm
- patients presenting with suspected intraepithelial neoplastic changes
- patients receiving acid suppressive therapy in standard dose for at least 4 weeks
Exclusion Criteria:
- no informed consent
- thrombocytopenia, quick <50%, PTT >50 sec
- patients with coronary heart disease or existent valve plasties
- women with potential pregnancy
- patients with chronic renal failure
- patients with allergies
- patients with chronic obstructive pulmonary disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
|---|
|
diagnostic accuracy of confocal laser scanning microscopy for detection of metaplasia or neoplasia in Barrett´s esophagus
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
|---|
|
inter- and intra observer variability for confocal laser scanning microscopy
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Alexander Meining, MD, Technical University Munich
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1129/04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.